Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer

StatusActive, Not Recruiting
PhaseEarly Phase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later Jun 1, 2026 → Jan 15, 2027
See other at-risk trials from M.D. Anderson Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 1, 2026 to Jan 15, 2027
    • Eligibility criteria expanded, about 15 words
    • Publications: details revised at 1 of 1 entry
    • Study description expanded, about 3 words
  2. 4 versions Re-verified since Feb 24, 2025, no change to tracked fieldsv12-v15
  3. Primary and study completion dates: Jun 1, 2024 to Jun 1, 2026v11
  4. Re-verified, no change to tracked fieldsv10
  5. Primary and study completion dates: Jun 1, 2023 to Jun 1, 2024
    • Enrollment target: 634 to 630
    • Eligibility criteria expanded, about 39 words
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary completion date: Jun 2022 to Jun 1, 2023v8 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 1260 to confirmed 634
    • Study completion date: Jun 2023 to Jun 1, 2023
    • Site details revised
  2. Re-verified, no change to tracked fieldsv7
  3. Site contact updatedv6
  4. Study completion date: Jun 2022 to Jun 2023
    • Eligibility criteria shortened, about 32 words
    • Study description shortened, about 109 words
    • Collaborators: 1 to 2
    v5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 2017 to Jun 16, 2017
    • Site details revised
    v4
  6. Primary and study completion dates: May 2022 to Jun 2022
    • Start date: May 2017 to Jun 2017
    • Eligibility criteria shortened, about 20 words
    • Study description expanded, about 122 words
    v3
  7. Site contact updatedv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical research study is to offer lung cancer screenings to smokers who want to change their smoking behaviors. All eligible participants will receive smoking cessation counseling and may be offered at least one form of smoking cessation drug. Different forms of counseling (the delivery of counseling and access to counseling) will be compared. This is an investigational study. Participants on this study will not be prescribed smoking drugs directly by the study staff. However, participants in this study may or may not receive smoking cessation drugs, depending on what the provider thinks is in the participants best interest. All smoking cessation drugs being used are FDA approved and commercially available. It is investigational to compare the different forms of counseling participants receive. Up to 1260 participants will be enrolled in this study. All will take part at MD Anderson.
Trial Details
NCT Number NCT03059940
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI), Pfizer
Conditions
(from sponsor)		 Smoking Cessation
Related terms Smoking Cessation
Enrollment 630 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov